DiscoverBack to Business: CalgaryThe Future of Gut Health: Pill‑Based Sampling, IBS Trials, and Calgary’s Innovation Ecosystem
The Future of Gut Health: Pill‑Based Sampling, IBS Trials, and Calgary’s Innovation Ecosystem

The Future of Gut Health: Pill‑Based Sampling, IBS Trials, and Calgary’s Innovation Ecosystem

Update: 2025-10-06
Share

Description

Welcome to the Back to Business Podcast, where we spotlight Calgary's industry leaders and delve into the heart of entrepreneurialism in our vibrant city!


Dr. Sabina Bruehlmann is the CEO of Nimble Science, a precision medicine technology company empowering clinicians, biopharma, digestive health and food companies  with access to precision GI health data leveraging novel medical technology. Nimble’s SIMBA GI Health Data Platform collects endoscopic quality intestinal fluid biopsies using a simple home kit.  Previously, she co-founded Zephyr Sleep Technologies, focusing on innovative diagnostic technologies where she led the R&D team.  Sabina holds a BSc in Mechanical Engineering and a PhD in Biomedical Engineering with 20 years of early-stage medical technology commercialization.


Get Connected With Sabina:

https://www.nimblesci.com/

https://www.linkedin.com/in/ sabinabruehlmann/


Visit www.calpeteclub.com for information on our next networking and membership opportunities.


Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

The Future of Gut Health: Pill‑Based Sampling, IBS Trials, and Calgary’s Innovation Ecosystem

The Future of Gut Health: Pill‑Based Sampling, IBS Trials, and Calgary’s Innovation Ecosystem